Summary
Oral administration of felodipine to 10 patients with mild essential hypertension acutely reduced systemic vascular resistance (SVR) by 40% after 30 min. The change in SVR was significantly related to age (r=−0.74). The reduction in the intraarterially measured brachial artery pressure was limited to 15/13 mmHg, due to a rise in cardiac output (CO). The tachycardia was sustained for 90 min, as was an elevation of plasma noradrenaline. There was a transient increase in stroke volume, associated with a reduction in pulmonary capillary wedge pressure, which was at least partly due to a reduced intravascular volume. In contrast to SVR, pulmonary vascular resistance was not affected by felodipine. Addition of intravascular metoprolol after 90 min decreased HR and CO and augmented SVR. The felodipine-induced rise in plasma renin activity (PRA) of 100% was completely reversed by metoprolol. Plasma angiotensin II (PA II) rose by 15% during felodipine, whereas plasma aldosterone concentration (PAC) was not affected. Thus, actuely administered felodipine was a potent dilator of systemic but not of pulmonary arterioles, it stimulated the sympathetic nervous system, and reduced left ventricular filling pressure. The rise in plasma renin did not result in a higher plasma aldosterone level, due partly to reduced generation of angiotensin II.
References
Ahnoff M (1984) Determination of felodipine in plasma by gaschromatography with electron capture detection. J Pharm Biomed Anal 2: 519–526
Andersson OK, Granérus G, Hedner T (1985) Felodipine: A calcium-inhibiting vasodilator in refractory hypertension. Drugs 29 [Suppl 2]: 102–108
Arnman K, Rydén L, Smedgård P, Thorhallsson E (1984) Felodipine in primary pulmonary hypertension. Report of two cases. Acta Med Scand 215: 275–280
Bertel O, Bühler FR, Kiowski W, Lutold TE (1980) Decreased beta-adrenoceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension. Hypertension 11: 130–138
Bühler FR, Hulthén LH, Kiowski W, Müller FB, Bolli P (1982) The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol 4 [Suppl 3]: S350-S357
Elmfeldt D, Hedner T (1985) Antihypertensive effects of felodipine compared with placebo. Drugs 29 [Suppl 2]: 109–116
Fagard R, Amery A, Reybrouck T, Lijnen P, Billiet L (1979) Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients. Circulation 60: 1214–1219
Fyhrquist F, Puutula L (1978) Faster radioimmunossay of angiotensin I at 37 °C. Clin Chem 24: 115–118
Gribbin BT, Pickering TG, Sleight P, Peto R (1971) The effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424–431
Hiramatsu K, Yamagishi F, Kubota T, Yamada T (1982) Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J 104: 1346–1350
Lijnen PJ, Amery AK, Fagard RH, Katz FH (1978a) Radioimmunoassay of angiotensin II in unextracted plasma. Clin Chim Acta 88: 403–412
Lijnen P, Amery A, Fagard R, Corvol P (1978b) Direct immunoassay of plasma aldosterone in normal subjects. Clin Chim Acta 84: 305–314
Millar JA, Struthers AD, Beastall GH, Reid JL (1982) Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans. J Cardiovasc Pharmacol 4 [Suppl 3]: S330-S334
Moerman EJ, De Schaepdryver AF (1984) Quantitation of catecholamines in urine and plasma. Clin Chim Acta 139: 321–333
Nordlander M, Di Bona GF, Ljung B, Yao T, Thorén P (1985) Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. Eur J Pharmacol 113: 25–36
Sluiter HE, Huysmans FTM, Thien TA, Van Lier HJJ, Koene RAP (1985) Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers. Drugs 29 [Suppl 2]: 26–35
Vierhapper H, Waldhäusl W (1982) Reduced pressor effect of angiotensin II and of noradrenaline in normal man following the oral administration of the calcium-antagonist nifedipine. Eur J Clin Med 12: 263–267
Wathen CG, Hannan WJ, Hill TWK, Muir AL (1983) Central and peripheral cardiovascular effects of felodipine in hypertension. J Hypertension 1 [Suppl 2]: 360–361
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fagard, R., Lijnen, P., Moerman, E. et al. Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension. Eur J Clin Pharmacol 32, 71–75 (1987). https://doi.org/10.1007/BF00609960
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609960